Schedule 13G ownership disclosure

ASSERTIO THERAPEUTICS INC

Security class unavailable · CUSIP: 04545L107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.5700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-19-003989
Form type
SC 13G/A
Filer
Assertio Therapeutics, Inc
CIK
CIK 1005201
Filed
Feb 08, 2019
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub